CALA vs. AMPE, EFTR, ONCSQ, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, and BFRIW
Should you be buying Calithera Biosciences stock or one of its competitors? The main competitors of Calithera Biosciences include Ampio Pharmaceuticals (AMPE), eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.
Calithera Biosciences vs.
Calithera Biosciences (NASDAQ:CALA) and Ampio Pharmaceuticals (NYSE:AMPE) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, community ranking, valuation, risk, media sentiment and analyst recommendations.
5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 6.6% of Calithera Biosciences shares are held by company insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, Calithera Biosciences and Calithera Biosciences both had 1 articles in the media. Calithera Biosciences' average media sentiment score of 0.00 equaled Ampio Pharmaceuticals'average media sentiment score.
Calithera Biosciences received 341 more outperform votes than Ampio Pharmaceuticals when rated by MarketBeat users. Likewise, 56.46% of users gave Calithera Biosciences an outperform vote while only 0.00% of users gave Ampio Pharmaceuticals an outperform vote.
Calithera Biosciences has a beta of -0.89, suggesting that its share price is 189% less volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 3.71, suggesting that its share price is 271% more volatile than the S&P 500.
Summary
Calithera Biosciences and Ampio Pharmaceuticals tied by winning 3 of the 6 factors compared between the two stocks.
Get Calithera Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Calithera Biosciences Competitors List
Related Companies and Tools
This page (NASDAQ:CALA) was last updated on 1/21/2025 by MarketBeat.com Staff
